Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Asset Utilization Ratio (2016 - 2024)

Trinity Biotech's Asset Utilization Ratio history spans 16 years, with the latest figure at 0.61 for Q4 2024.

  • On a quarterly basis, Asset Utilization Ratio fell 33.61% to 0.61 in Q4 2024 year-over-year; TTM through Dec 2024 was 0.61, a 33.61% decrease, with the full-year FY2025 number at 0.42, down 44.47% from a year prior.
  • Asset Utilization Ratio hit 0.61 in Q4 2024 for Trinity Biotech, down from 0.62 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for TRIB hit a ceiling of 0.92 in Q4 2023 and a floor of 0.61 in Q4 2024.
  • Historically, Asset Utilization Ratio has averaged 0.73 across 5 years, with a median of 0.71 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: soared 40.38% in 2023 and later crashed 33.61% in 2024.
  • Tracing TRIB's Asset Utilization Ratio over 5 years: stood at 0.77 in 2020, then increased by 0.51% to 0.77 in 2021, then dropped by 14.46% to 0.66 in 2022, then soared by 40.38% to 0.92 in 2023, then crashed by 33.61% to 0.61 in 2024.
  • Business Quant data shows Asset Utilization Ratio for TRIB at 0.61 in Q4 2024, 0.62 in Q3 2024, and 0.64 in Q2 2024.